Arcturus Therapeutics (ARCT)
US Market

Arcturus Therapeutics (ARCT) Financial Statements


Arcturus Therapeutics Financial Overview

Arcturus Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.908; its P/E ratio is -6.21; Arcturus Therapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 25.08M$ 45.14M$ 10.52M$ 80.28M$ 160.29M
Gross Profit$ 30.86M$ 45.14M$ 10.52M$ 80.28M$ 160.29M
EBIT$ -11.44M$ -15.33M$ -51.97M$ 50.86M$ 119.14M
EBITDA$ -10.63M$ -14.50M$ -51.24M$ 51.44M$ 118.24M
Net Income Common Stockholders$ -11.71M$ -16.22M$ -52.55M$ 50.75M$ 117.35M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 292.00M$ 311.92M$ 323.47M$ 327.94M$ 391.88M
Total Assets$ 429.40M$ 457.65M$ 430.65M$ 470.86M$ 450.39M
Total Debt$ 25.91M$ 47.02M$ 28.11M$ 29.19M$ 90.87M
Net Debt$ -266.10M$ -264.90M$ -295.36M$ -298.75M$ -301.01M
Total Liabilities$ 150.89M$ 177.59M$ 145.47M$ 141.62M$ 180.07M
Stockholders Equity$ 278.51M$ 280.06M$ 285.21M$ 329.25M$ 270.31M
Cash Flow-
Free Cash Flow$ -1.50M$ -33.39M$ 50.45M$ -36.56M$ 156.45M
Operating Cash Flow$ -629.00K$ -32.41M$ 50.81M$ -35.87M$ 160.26M
Investing Cash Flow$ -875.00K$ -981.00K$ -354.00K$ -691.00K$ -3.81M
Financing Cash Flow$ -18.66M$ 21.84M$ 94.00K$ -27.36M$ -2.23M
Currency in USD

Arcturus Therapeutics Earnings and Revenue History

Arcturus Therapeutics Debt to Assets

Arcturus Therapeutics Cash Flow

Arcturus Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis